Frank P. Luyten

Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA.

KBC Insurance NV provides risk management and non-life insurance services. The firm offers liability insurance brokerage and industrial accidents, car & fleet, asset protection and debtor management services. The company is headquartered in Brussels, Belgium.

Vlaamse Instelling Voor Technologisch Onderzoek NV provides customer research services. The company provides its services to the energy suppliers, appliance builders, end users and government sectors. The company was founded in 1991 and is headquartered in Mol, Belgium.

Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.

DSM Venturing BV (DSM Venturing) is the venture capital arm of Royal DSM NV in the Netherlands founded in 2001. DSM Venturing BV is headquartered in Geleen.

Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa.

PharmaDM NV provides drug discovery data analysis solutions. It offers its solutions based on mining integrated chemical, biological, and clinical data. The firm's products include DMax, AlphaDMax, and IDMax. The company was founded by Dr. Luc Dehaspe, Dr. Ross D. King, and Dr. Ashwin Srinivasan in November 2000 and is headquartered in Heverlee, Belgium.

Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona.

Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom.

it4ip SA engages in the development and manufacture of porous templates and membranes. Its applications are used for direct observation and rapid quantification of biological cells or µ-organisms for cancer diagnosis, diffusion control in biosensors, particle capture tests, rare event recovery, and fuel cells. The company was founded by Roger Marcel Henri Legras, Laurent Marie Ghislain Jonckheere, Etienne Robert Christian Ferain, Marie Rose Laure Germaine Delleur, Yves-Jacques Schneider, and Henri Hanot in 2006 and is headquartered in Louvain-la-Neuve, Belgium.

Biotreatment SA develops processes for biological treatment of environment and specifically the treatment of hydrocarbons, organic waste and waste management. It offers analysis of organic waste, selection of micro-organisms in natural habitats, production of micro-organisms, and analysis of polluted environments. The company is headquartered in Liege, Belgium.

ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands.

AACC International is a non-profit organization of members who are specialists in the use of cereal grains in foods. The Association was previously known as the American Association of Cereal Chemists (AACC). They publish Cereal Chemistry and Cereal Foods World as well as books on grain and food science. In addition to many other opportunities for professional growth, the association holds an annual meeting with exhibition, provides short courses taught by well-known experts in the field, and offers the online library of industry netcasts, the Cereal Science Knowledge Database. AACC International also offers international check sample and proficiency testing service, analytical sanitation certification as well as regional sections and subject matter divisions. The company was founded in 1915 and is headquartered in St. Paul, MN.

Bio-Incubator Leuven is a dynamic and innovative environment that provides lab space and support to R&D-intensive life sciences companies. The private company offers customizable modules that can be modified to meet the specific requirements of each client. The company is based in Leuven, Belgium. Leuven's knowledge institutes, including KU Leuven, University Hospitals Leuven, VIB, and IMEC, generate a huge outflow of knowledge that entails a myriad of innovative ideas for new and existing companies. The CEO of the Belgian company is Michaël de Blauwe.

FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen.

PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

United Telecom NV develops software technologies for mobile operators. It provides fixed and mobile telephony and VDSL products. The company was founded in 1990 and is headquartered in Rotselaar, Belgium.

Federation of Enterprises in Belgium ASBL/VZW fka Federation des Entreprises de Belgique is the only multi-sector employers' organization representing companies in all three regions of Belgium. Its members, Belgium's leading sectoral federations, represent companies in key industrial and service sectors. The company was founded in 1973 and is headquartered in Brussels, Belgium.

Guberna vzw is an organization that aims to promote good governance in all types of organizations. The private company is based in Brussels, Belgium. The Belgian company believes that good governance leads to better organizations, which in turn contribute to a better world. To achieve this mission, Guberna focuses on three strategic pillars\: knowledge development, lifelong learning, and networking. Good governance involves boards, control, accountability, supervision, and control, and is a means to realize the organizational strategy.

Cliniques Universitaires Saint-Luc operates as a hospital which provides reference care and treats serious, rare or complex diseases of patients. The company was founded on August 23, 1976 and is headquartered in Brussels, Belgium.

Ovizio Imaging Systems SA develops and markets imaging systems and sensors. Its microscopes include iLine F, iLine M, iLine S and QMod. The company was founded by Catherine Yourassowsky, Frank Dubois, Philip Mathuis and Serge Jooris in December 2009 and is headquartered in Brussels, Belgium.

Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands.

Artialis SA develops and commercializes immunoassays for the diagnostic and the prognostic disorders. Its products include Urine F3F ELISA, Urine COLL2-2NO2 ELISA, Urine COLL2-1NO2 ELISA and Urine COLL2-1 ELISA. The firm engages in development, analysis and marketing diagnostic kits including in the field of diseases of the musculoskeletal system of humans and animals. The company was founded in 2010 by Yves Henrotin and is headquartered in Liege, Belgium.

OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium.

Brightlands Venture Partners is an independent regional venture capital firm headquartered in Brightlands, Netherlands. The firm was founded in 2004.

Fedrus International NV operates as a holding company with interests in roofing and façade materials. The company was founded on May 21, 2015 and is headquartered in Puurs, Belgium.

Part of Tusk Therapeutics SA, Tusk Therapeutics NV operates as a research organization. The company is based in Vlaams Brabant, Belgium.

Tusk Therapeutics SA develops and manufactures therapeutic products. The private company is based in Luxembourg, Luxembourg. and has subsidiaries in Belgium. Luc Dochez has been the CEO of the Luxembourger company since 2015.

Z.org KU Leuven provides psychiatric care services. The private company is based in Leuven, Belgium. The Belgian company was founded in 2014. The CEO is Wim Tambeur.